Highlights
- Testosterone therapy modestly improves sexual function, corrects anemia, and increases bone density in older men with hypogonadism.
- Risks include increased venous thromboembolism, clinical fractures, and atrial fibrillation; no significant increase in major cardiovascular events or prostate cancer observed in trials to date.
- Therapy should be reserved for men with unequivocally low testosterone levels and persistent symptoms after careful diagnostic workup.
Study Background and Disease Burden
Specialty calculators
For clinical reference; use professional judgment.
